Search Results

There are 34364 results for: content related to: Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: Drug-specific comparisons in the Swedish Biologics Register

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results

    Arthritis & Rheumatism

    Volume 64, Issue 1, January 2012, Pages: 21–32, D. H. Solomon, E. Mercer and A. Kavanaugh

    Version of Record online : 29 DEC 2011, DOI: 10.1002/art.30653

  4. You have free access to this content
    Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

    Arthritis & Rheumatology

    Volume 66, Issue 5, May 2014, Pages: 1282–1290, K. Hellgren, K. E. Smedby, C. Backlin, C. Sundstrom, N. Feltelius, J. K. Eriksson, E. Baecklund and J. Askling

    Version of Record online : 28 APR 2014, DOI: 10.1002/art.38339

  5. Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis

    International Journal of Rheumatic Diseases

    Volume 13, Issue 1, February 2010, Pages: 12–26, Veera S. KATIKIREDDI, Samuel L. WHITTLE and Catherine L. HILL

    Version of Record online : 21 JAN 2010, DOI: 10.1111/j.1756-185X.2009.01457.x

  6. Safety of tumor necrosis factor inhibitor therapy in patients with a prior malignancy

    International Journal of Rheumatic Diseases

    Seung-Hyeon Bae, Soo Min Ahn, Doo-Ho Lim, Seokchan Hong, Yong-Gil Kim, Bin Yoo and Chang-Keun Lee

    Version of Record online : 29 APR 2016, DOI: 10.1111/1756-185X.12852

  7. Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database

    Fundamental & Clinical Pharmacology

    Volume 30, Issue 2, April 2016, Pages: 162–171, Layla Saliba, Guillaume Moulis, Malak Abou Taam, Vanessa Rousseau, Leila Chebane, Nadine Petitpain, Bernadette Baldin, Grégory Pugnet, Jean-Louis Montastruc and Haleh Bagheri

    Version of Record online : 23 DEC 2015, DOI: 10.1111/fcp.12171

  8. You have free access to this content
    Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

    Arthritis & Rheumatism

    Volume 65, Issue 5, May 2013, Pages: 1213–1223, Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, Martin Dehn Andersen, Ulrik Tarp, Anne Gitte Loft, Hanne M. Lindegaard, Mette Holland-Fischer, Henrik Nordin, Dorte Vendelbo Jensen, Christian Holkmann Olsen and Merete Lund Hetland

    Version of Record online : 23 APR 2013, DOI: 10.1002/art.37876

  9. You have free access to this content
    Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 64, Issue 1, January 2012, Pages: 42–52, Lotta Ljung, Julia F. Simard, Lennart Jacobsson, Solbritt Rantapää-Dahlqvist, Johan Askling and Anti-Rheumatic Therapy in Sweden (ARTIS) Study Group

    Version of Record online : 29 DEC 2011, DOI: 10.1002/art.30654

  10. You have free access to this content
    2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 68, Issue 1, January 2016, Pages: 1–25, Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges Jr., Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta Vaysbrot, Christine McNaughton, Mikala Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James O'Dell, Charles King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara Drevlow, Seth Ginsberg, James Grober, E. William St.Clair, Elizabeth Tindall, Amy S. Miller and Timothy McAlindon

    Version of Record online : 6 NOV 2015, DOI: 10.1002/acr.22783

  11. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up

    International Journal of Rheumatic Diseases

    Volume 15, Issue 3, June 2012, Pages: 330–335, Ahmed M. Dewedar, Medhat A. Shalaby, Sulaiman Al-Homaid, Ahmed M. Mahfouz, Osama A. Shams and Ahmed Fathy

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1756-185X.2012.01715.x

  12. You have free access to this content
    Does cancer that occurs during or after anti–tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents

    Arthritis & Rheumatism

    Volume 63, Issue 7, July 2011, Pages: 1812–1822, Pauline Raaschou, Julia F. Simard, Martin Neovius, Johan Askling and Anti-Rheumatic Therapy in Sweden Study Group

    Version of Record online : 29 JUN 2011, DOI: 10.1002/art.30247

  13. You have free access to this content
    Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study

    Arthritis Care & Research

    Volume 67, Issue 8, August 2015, Pages: 1137–1149, L. E. Kristensen, A. K. Jakobsen, J. Askling, F. Nilsson and L. T. H. Jacobsson

    Version of Record online : 26 JUL 2015, DOI: 10.1002/acr.22555

  14. You have free access to this content
    2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Arthritis & Rheumatology

    Volume 68, Issue 1, January 2016, Pages: 1–26, Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges Jr., Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta Vaysbrot, Christine McNaughton, Mikala Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James O'Dell, Charles King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara Drevlow, Seth Ginsberg, James Grober, E. William St.Clair, Elizabeth Tindall, Amy S. Miller and Timothy McAlindon

    Version of Record online : 6 NOV 2015, DOI: 10.1002/art.39480

  15. You have free access to this content
    Reply

    Arthritis & Rheumatism

    Volume 65, Issue 6, June 2013, Pages: 1671–1672, Julia F. Simard, Martin Neovius and Johan Askling

    Version of Record online : 30 MAY 2013, DOI: 10.1002/art.37929

  16. You have free access to this content
    Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update

    Journal of Internal Medicine

    Volume 264, Issue 6, December 2008, Pages: 514–527, K. E. Smedby, J. Askling, X. Mariette and E. Baecklund

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2796.2008.02029.x

  17. You have free access to this content
    Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1263–1271, Timothy Beukelman, Kevin Haynes, Jeffrey R. Curtis, Fenglong Xie, Lang Chen, Christina J. Bemrich-Stolz, Elizabeth Delzell, Kenneth G. Saag, Daniel H. Solomon, James D. Lewis and Safety Assessment of Biological Therapeutics Collaboration

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.34348

  18. Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

    Drug Development Research

    Volume 76, Issue 8, December 2015, Pages: 419–427, Rui Pereira, Paula Lago, Raquel Faria and Tiago Torres

    Version of Record online : 20 OCT 2015, DOI: 10.1002/ddr.21285

  19. Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three-Year Followup and Predictors

    Arthritis Care & Research

    Salima F. E. van Weely, Eva L. Kneepkens, Mike T. Nurmohamed, Joost Dekker and Irene E. van der Horst-Bruinsma

    Version of Record online : 19 AUG 2016, DOI: 10.1002/acr.22869

  20. Effect of comedication with conventional synthetic DMARDs on TNF inhibitors-retention in patients with spondyloarthritis: A prospective cohort

    Arthritis & Rheumatology

    Accepted manuscript online: 6 JUN 2016, Alexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, Pedro Ávila-Ribeiro, Rita Fonseca, Joana Borges, Lídia Teixeira, Pedro Carvalho, Marcos Cerqueira, Joana Neves, Tiago Meirinhos, Anabela Barcelos, Graça Sequeira, Maria João Salvador, José António Canas da Silva, Helena Santos, Miguel Bernardes, Elsa Vieira-Sousa, Helena Canhão, Jaime C. Branco, Fernando Pimentel-Santos and Robert Landewé

    DOI: 10.1002/art.39772